Five months after announcing its intentions to gather genome sequences from 2 million people, pharmaceutical giant AstraZeneca has selected geneticist David Goldstein to head up the task.
From Nature
View Full Article
advertisement
Home → Opinion → Interviews → Why Big Pharma Wants to Collect 2 Million Genomes → Full Text
Why Big Pharma Wants to Collect 2 Million Genomes
By Nature
September 30, 2016
![[article image]](https://cacm.acm.org/system/assets/0002/5183/93016.nature.david_goldstein_columbia_univ.large.jpg?1476779525&1475263510 "David Goldstein, Columbia")
0 Comments
No entries found